Funds · 13F holdings

HighMark Wealth Management LLC

13F holdings for Q2 2026 · ST. PAUL, MN · filed August 12, 2026

HighMark Wealth Management LLC reported $299M in 13F securities across 565 holdings for Q2 2026, in a Form 13F filed August 12, 2026. The largest positions were iShares TR (27.6%), Fidelity Covington Trust (6.6%), AXGN (5.3%). Reported value rose 21.5% from the quarter before. It opened 45 new positions, added to 155, trimmed 91 and sold out of 38.

13F value Q2 2026
$299M
Holdings
565
Change vs prior quarter
+21.5%
Rank by 13F value
#5,271

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Top holdings

StockValueWeightSharesChange in sharesMove
iShares TR$82.3M27.6%109,892-6.0%Trimmed
Fidelity Covington Trust$19.7M6.6%254,403+3179938%Added
AXGN Axogen Inc.$15.8M5.3%341,390-1.0%Trimmed
iShares TR$15.3M5.1%51,019-6.6%Trimmed
iShares Msci Eafe Value ETF$15.2M5.1%199,183-9.6%Trimmed
iShares Core S&P Small Cap ETF$13.3M4.5%89,888-0.9%Trimmed
Vanguard Index FDS$10.7M3.6%15,529-5.9%Trimmed
NEO NeoGenomics Inc.$8.9M3.0%612,534+5.6%Added
IUSV iShares Core S&P U.S. Value ETF$8.3M2.8%75,506-6.2%Trimmed
SIBN SI-BONE Inc.$6.9M2.3%425,049+165.9%Added
DWAS Invesco DWA SmallCap Momentum ETF$5.9M2.0%46,538-0.7%Trimmed
WFC Wells Fargo & Company$5.7M1.9%68,6440%Unchanged
iShares Core S&P Mid-Cap ETF$4.8M1.6%62,399+2.8%Added
Apogee Therapeutics Inc Com$4.3M1.4%32,266NewNew
TWST Twist Bioscience Corporation$4.0M1.3%39,030-0.7%Trimmed
DUOT Duos Technologies Group Inc.$3.5M1.2%289,884NewNew
TLT iShares 20+ Year Treasury Bond ETF$3.1M1.0%36,113+1.0%Added
MASS 908 Devices Inc.$3.0M1.0%339,783+6.4%Added
ANAB AnaptysBio Inc.$2.7M0.9%39,716-57.8%Trimmed
NPCE Neuropace Inc.$2.6M0.9%163,000+158.7%Added
NVDA NVIDIA Corporation$2.4M0.8%11,844-7.3%Trimmed
ATRC AtriCure Inc.$2.3M0.8%83,7200%Unchanged
AAPL Apple Inc.$2.2M0.7%7,608-3.0%Trimmed
EWTX Edgewise Therapeutics Inc.$2.2M0.7%53,1790%Unchanged
LLY Eli Lilly and Company$2.1M0.7%1,734+0.3%Added

Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $299M in share positions; options and bonds count in the 13F value but not here.

Biggest buys in Q2 2026

  1. Fidelity Covington Trust Added+$19.7M
  2. SIBN SI-BONE Inc. Added+$4.3M
  3. Apogee Therapeutics Inc Com New+$4.3M
  4. DUOT Duos Technologies Group Inc. New+$3.5M
  5. NPCE Neuropace Inc. Added+$1.6M
  6. Crinetics Pharmaceuticals Inc Com Added+$677K
  7. NEO NeoGenomics Inc. Added+$477K
  8. JPMorgan U.s. Tech Leaders ETF Added+$375K
  9. Oneok Inc New New+$239K
  10. SNDK Sandisk Corporation New+$227K

Biggest sells in Q2 2026

  1. Centessa Pharmaceuticals PLC Sold out-$9.4M
  2. iShares TR Trimmed-$5.3M
  3. ANAB AnaptysBio Inc. Trimmed-$3.7M
  4. iShares Msci Eafe Value ETF Trimmed-$1.6M
  5. PIPR Piper Sandler Companies Trimmed-$1.1M
  6. iShares TR Trimmed-$1.1M
  7. ORGO Organogenesis Holdings Inc. Trimmed-$708K
  8. Vanguard Index FDS Trimmed-$674K
  9. IUSV iShares Core S&P U.S. Value ETF Trimmed-$554K
  10. NVDA NVIDIA Corporation Trimmed-$186K

The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 45 new, 155 added, 91 trimmed, 38 sold out.

Sector mix

13F value by quarter

Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
Reported 13F value: Q1 2024 $161M, Q2 2024 $166M, Q3 2024 $183M, Q4 2024 $174M, Q1 2025 $169M, Q2 2025 $205M, Q3 2025 $227M, Q4 2025 $245M, Q1 2026 $246M, Q2 2026 $299M.

More holdings

StockValueWeightSharesChange in sharesMove
TRV The Travelers Companies Inc.$1.9M0.6%5,606+0.6%Added
MSFT Microsoft Corporation$1.7M0.6%4,684+4.0%Added
HCAT Health Catalyst Inc$1.7M0.6%871,082-3.5%Trimmed
MMM 3M Company$1.6M0.5%9,733-0.3%Trimmed
iShares S&P Mid-Cap 400 Value ETF$1.5M0.5%9,998+7.8%Added
Crinetics Pharmaceuticals Inc Com$1.4M0.5%38,595+88.3%Added
iShares TR$1.4M0.5%6,475+7.6%Added
XENE Xenon Pharmaceuticals Inc.$1.4M0.5%23,0000%Unchanged
iShares TR$1.3M0.4%5,909+2.9%Added
TSLA Tesla Inc.$1.2M0.4%2,8340%Unchanged
XEL Xcel Energy Inc.$1.1M0.4%13,138+0.5%Added
iShares TR$1.0M0.3%9,335+3.7%Added
USB U.S. Bancorp$1.0M0.3%16,643-1.9%Trimmed
Vanguard Index FDS$919K0.3%2,482+0.3%Added
iShares TR$914K0.3%9,230+2.0%Added
HSBC HSBC Holdings plc.$857K0.3%9,0080%Unchanged
SPY State Street SPDR S&P 500 ETF Trust Unit$807K0.3%1,081-3.7%Trimmed
GOOGL Alphabet Inc.$784K0.3%2,193+8.2%Added
PG Procter & Gamble Company$764K0.3%5,210+1.4%Added
AMZN Amazon.com Inc.$711K0.2%2,983+5.2%Added
SPDR Index SHS FDS$695K0.2%13,425-10.5%Trimmed
AUPH Aurinia Pharmaceuticals Inc$597K0.2%35,1960%Unchanged
ECL Ecolab Inc.$585K0.2%2,101+0.3%Added
MO Altria Group Inc.$568K0.2%7,889+1.6%Added
JPMorgan U.s. Tech Leaders ETF$567K0.2%5,085+194.6%Added

Showing the 50 largest of 559 share positions. The full filing on SEC EDGAR

Questions about HighMark Wealth Management LLC

What does HighMark Wealth Management LLC own?
In its Form 13F for Q2 2026, HighMark Wealth Management LLC reported 565 holdings worth $299M. The five largest were iShares TR, Fidelity Covington Trust, AXGN, iShares TR, iShares Msci Eafe Value ETF.
What did HighMark Wealth Management LLC buy and sell in Q2 2026?
HighMark Wealth Management LLC opened 45 new positions, added to 155, trimmed 91 and sold out of 38 compared with the quarter before.
When did HighMark Wealth Management LLC file its latest 13F?
Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed August 12, 2026.

From Form 13F filed by HighMark Wealth Management LLC (SEC CIK 0001802451) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds · Get this as JSON